Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOBUNOLOL vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOBUNOLOL vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOBUNOLOL LEVOMILNACIPRAN
Total FAERS Reports 144 1,378
Deaths Reported 2 382
Death Rate 1.4% 27.7%
Hospitalizations 7 378
Average Patient Age 76.5 yrs 46.4 yrs
% Female Patients 65.8% 80.2%
FDA Approval Date Aug 3, 2000 Feb 4, 2019
Manufacturer Bausch & Lomb Incorporated Allergan, Inc.
Route OPHTHALMIC ORAL
Marketing Status Prescription Prescription